Search

Displaying results 6371 - 6380 of 7673 in total
  1. Drug

    Pirinidazole

    go.drugbank.com/drugs/DB21413
    Experimental

    Pirinidazole has a monoisotopic molecular weight of 250.05 Da.

  2. Drug

    Tifurac

    go.drugbank.com/drugs/DB21415
    Experimental

    Tifurac has a monoisotopic molecular weight of 326.06 Da.

  3. Drug

    Pilavapadin

    go.drugbank.com/drugs/DB21552
    Investigational

    Pilavapadin has a monoisotopic molecular weight of 385.18 Da.

  4. Drug

    Canocapavir

    go.drugbank.com/drugs/DB21570
    Experimental

    Canocapavir has a monoisotopic molecular weight of 561.08 Da.

  5. Drug

    Emzeltrectinib

    go.drugbank.com/drugs/DB21605
    Experimental

    Emzeltrectinib has a monoisotopic molecular weight of 376.13 Da.

  6. Drug

    Mitoquinone

    go.drugbank.com/drugs/DB05063
    Investigational

    Mitochondrial dysfunction also has been shown to represent an early critical event in the pathogenesis of the sporadic form of Parkinson's disease. … Clinical studies by the Parkinson's Study Group show that very high doses of an antioxidant called Coenzyme Q (which Mitoquinone effectively targets into mitochondria) appear to slow the progression of

  7. Drug

    SCIB1

    go.drugbank.com/drugs/DB18439
    Investigational

    SCIB1 is an investigational cancer vaccine being developed by Scancell Ltd. It is being investigated for the treatment of melanoma.

  8. Drug

    NGN-401

    go.drugbank.com/drugs/DB18594
    Investigational

    NGN-401 is a recombinant serotype 9 adeno-associated virus (AAV) encoding an intron encoding a miRNA generating sequence, complementary miRNA binding sites and a full-length human methyl cytosine binding

    Synonyms: Recombinant serotype 9 adeno-associated virus (AAV) encoding an intron encoding a miRNA generating sequence, complementary miRNA binding sites and a full-length human methyl cytosine binding protein 2
  9. Drug

    QazCovid-in

    go.drugbank.com/drugs/DB16441
    Investigational

    The QazCovid-in vaccine, an inactivated vaccine, was developed and tested in the Kazakh Research Institute for Biological Safety Problems[L30628].

  10. Drug

    Devafidugene civaparvovec

    go.drugbank.com/drugs/DB16790
    Investigational

    Devafidugene civaparvovec is an investigational _in vivo_ genome editing product.